SCHEMBL30101423

SCHEMBL30101423

c1ccc(C(CN2CCCCC2)c2ccccc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
HTT P42858 2/20 0.53
MITF O75030 1/20 0.53
RAB9A P51151 1/20 0.53
GFER P55789 1/20 0.53
PAX8 Q06710 1/20 0.53
ATM Q13315 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
CYP2D6 P10635 5/20 0.52
CYP1A2 P05177 4/20 0.52
CYP3A4 P08684 4/20 0.52
CYP2C9 P11712 4/20 0.52
KCNA5 P22460 4/20 0.52
CYP2C19 P33261 4/20 0.52
KCNH2 Q12809 4/20 0.52
KCNE1 P15382 1/20 0.52
TSHR P16473 1/20 0.50
HIF1A Q16665 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17810249 0.98 ALDH1A1 (0.55) ALDH1A1MEN1KMT2AHTTMITF
SCHEMBL23775098 0.93 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AHTTMITF
SCHEMBL6262165 0.87 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AHTTMITF
SCHEMBL4821437 0.82 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AHTTMITF
SCHEMBL3051447 0.82 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AHTTMITF
SCHEMBL12573567 0.82 GAA (0.69) ALDH1A1MEN1KMT2AHTTMITF
SCHEMBL7792404 0.82 ALDH1A1 (0.67) ALDH1A1KMT2AHTTMITFRAB9A
SCHEMBL15767970 0.82 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AHTTMITF
SCHEMBL8223804 0.82 GAA (0.69) ALDH1A1MEN1KMT2AHTTMITF
SCHEMBL1460306 0.82 GAA (0.69) ALDH1A1MEN1KMT2AHTTMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034120-A1 PYRIDAZINONES AS PARP7 INHIBITORS RIBON THERAPEUTICS, INC. 2025-01-30 US disclosed
US-20230192664-A1 PYRIDAZINONES AS PARP7 INHIBITORS ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE 2023-06-22 US disclosed
US-11566020-B1 Pyridazinones as PARP7 inhibitors RIBON THERAPEUTICS, INC. (US) 2023-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034120-A1 PYRIDAZINONES AS PARP7 INHIBITORS PARP2, PARP1, PARP4 ALDH1A1 1033/4885MEN1 2745/4885KMT2A 1137/4885
US-11566020-B1 Pyridazinones as PARP7 inhibitors PARP2, PARP1, PARP4 ALDH1A1 1033/4885MEN1 2745/4885KMT2A 1137/4885
US-20230192664-A1 PYRIDAZINONES AS PARP7 INHIBITORS PARP2, PARP1, PARP4 ALDH1A1 1033/4885MEN1 2745/4885KMT2A 1137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.